The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?

The S&P 500's forward PEG ratio is about 0.7, its lowest relative level in at least 31 years, despite a forward P/E of 19.2x and the index trading near record highs. The low PEG reflects analyst forecasts for 26.8% Q4 2026 earnings growth, 15.4% growth in 2027, and 27.3% annualized growth over the next five years, largely tied to AI-driven productivity and profit expectations. The article cautions that these projections are unusually high versus the S&P 500's 7.5% long-run earnings-compound rate, but argues there remains room for equities to advance if large-cap companies deliver high-teens EPS growth.

Analysis

The apparent index-level valuation cushion is unusually dependent on the durability of a narrow set of long-duration profit assumptions rather than on current broad-market cash generation. A 27% five-year EPS CAGR embedded in aggregate estimates leaves little room for the normal sequence of estimate cuts; if realized growth reverts toward a 10-12% range, the relevant outcome is not merely a higher PEG but simultaneous EPS de-rating and multiple compression. The immediate risk is therefore concentrated in index-heavy AI beneficiaries and passive vehicles (SPY, QQQ), where the same earnings narrative supports both fundamentals and positioning.

NVDA remains the highest-beta expression of this setup: upside requires hyperscaler capex and inference monetization to validate a multiyear earnings staircase, while even a modest reduction in customers' capex intensity can reset the terminal-growth debate. NFLX is comparatively insulated from AI-capex expectations and offers a cleaner idiosyncratic earnings path through advertising, pricing, and margin conversion; it could outperform in a rotation away from infrastructure-led growth without requiring a market drawdown. GETY has no clear read-through from broad PEG arguments and should not be treated as an AI valuation proxy.

Over the next 1-3 months, the key catalyst is earnings-report guidance: revisions to 2027 revenue, capex, and gross-margin assumptions matter more than reported quarterly beats. Over 6-18 months, productivity gains must diffuse beyond mega-cap technology to validate index-level profit forecasts; otherwise market leadership likely narrows further before a broader valuation reset. Contrarianly, a high headline growth forecast is not itself bearish if nominal growth, buybacks, and operating leverage remain supportive—but the investable response is dispersion, not indiscriminate beta.

Falsification of the cautious view would be sustained upward breadth in EPS revisions outside semis/software, stable real yields, and hyperscaler capex guidance that remains elevated without rising depreciation or free-cash-flow stress. Conversely, two consecutive quarters of downward 2027 S&P 500 EPS revisions, or a material capex slowdown from major AI buyers, would make the valuation adjustment more acute.

Key Decisions for Investors

• Maintain a 1-3 month relative-value tilt: long NFLX versus short QQQ in beta-adjusted size. NFLX has identifiable company-specific margin and monetization levers, while QQQ carries greater sensitivity to long-duration AI estimate risk; reassess if NFLX misses subscriber/advertising execution or QQQ earnings revisions broaden upward.
• Do not add outright NVDA exposure solely on the low-PEG narrative. Add only after customer capex guidance and NVDA backlog/supply commentary confirm 2027 demand visibility; use defined-risk call spreads rather than uncovered downside exposure given sharp multiple sensitivity to estimate revisions.
• For existing broad-equity longs, buy 3-6 month SPY put spreads rather than exit core exposure outright. The hedge is justified while index earnings expectations remain unusually elevated; take it off if broad EPS-revision breadth turns positive for two reporting cycles.
• Monitor a dispersion trigger: initiate a more defensive long-quality/short-index basket if consensus 2027 S&P 500 EPS falls by 3-5% or more. Favor cash-generative, self-funded growth names over capital-intensive AI beneficiaries whose free-cash-flow conversion deteriorates as capex rises.